This report is being filed due to recurrent mitral regurgitation, tissue injury, and worsening heart failure.Crd_1002 - expand g4 phase 1 and phase 2 study.Patient id: (b)(4).It was reported that on (b)(6) 2022, the patient presented with degenerative mitral regurgitation (mr) with posterior leaflet prolapse.Two mitraclips were implanted, reducing the mr to grade 1+.There was no device deficiency.On (b)(6) 2023, a follow-up echocardiogram was performed.Mr grade 2+ was noted.On (b)(6) 2024, elevated nt-probnp (heart failure lab) was noted.On (b)(6) 2024, eccentric, moderate mitral insufficiency at a1p1 was noted due to partial rupture of p1 likely related to clip 2 (cds0702 xtw, 10304r188) traction.Movement was noted due to the prolapse without any device deficiency/malfunction.Paradoxical aortic stenosis and severe functional tricuspid insufficiency (ti) were observed.Both the aortic stenosis and ti were deemed unrelated to the mitraclip device.The left ventricular ejection fraction was preserved.No treatment was provided.There was no device malfunction.The mitraclips remained stable and well seated.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The investigation determined the reported recurrent mr and heart failure appear to be related to the reported tissue injury.The tissue injury appears to be related to the movement due to the prolapse.Mr, tissue injury, and heart failure are listed in the instructions for use as known possible complications associated with the mitraclip procedures.The reported serious injury/illness/impairment was a result of case specific circumstance as no intervention performed to address the patient effects.There is no indication of a product issue with respect to manufacture, design or labeling.
|